| Date Filed | Type | Description |
| 08/10/2023 |
4
| Loh Evan (CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 168,750 shares
@ $0
Sold 48,967 shares
@ $2.2, valued at
$107.7k
|
|
| 03/03/2023 |
4
| Loh Evan (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 12/14/2022 |
4
| Loh Evan (CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 37,831 shares
@ $1.98, valued at
$74.9k
Sold 61,919 shares
@ $1.96, valued at
$121.4k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2022 |
4
| Loh Evan (CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 236,250 shares
@ $0 |
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/15/2020 |
4
| Loh Evan (CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 18,585 shares
@ $6.95, valued at
$129.2k
Sold 26,415 shares
@ $6.71, valued at
$177.2k
|
|
| 11/16/2020 |
4
| Loh Evan (CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 shares
@ $0
Sold 20,928 shares
@ $5.93, valued at
$124.1k
|
|
| 11/02/2020 |
4
| Loh Evan (CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Exercised 39,479 options to buy
@ $4.3, valued at
$169.8k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| Loh Evan (CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 14,514 shares
@ $3.1, valued at
$45k
|
|
| 10/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2019 |
4
| Loh Evan (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $14.31, valued at
$143.1k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2018 |
4
| Loh Evan (President, COO and CMO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 5,525 shares
@ $6.76, valued at
$37.3k
Sold 6,000 shares
@ $6.27, valued at
$37.6k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2018 |
4
| Loh Evan (President, COO and CMO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 12,000 shares
@ $9.97, valued at
$119.6k
|
|
| 04/10/2018 |
4
| Loh Evan (President, COO and CMO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 8,084 shares
@ $12.7, valued at
$102.7k
|
|
| 04/05/2018 |
4
| Loh Evan (President, COO and CMO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 19,500 shares
@ $0 |
|
| 03/16/2018 |
4
| Loh Evan (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $9.5, valued at
$95k
|
|
| 02/16/2018 |
4
| Loh Evan (President, COO and CMO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 58,500 shares
@ $0 |
|
|